Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients
NCT00699816
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
230
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
BIOLOGICAL:
Immuncell-LC
Sponsor
GC Cell Corporation